Prognostic Biomarker: A biomarker used to identify likelihood of a clinical event, disease recurrence or progression in patients who have the disease.
BEST (Biomarkers, EndpointS, and other Tools) Resource. FDA-NIH Biomarker Working Group. Last Updated: November 29, 2021. https://www.ncbi.nlm.nih.gov/books/NBK326791/pdf/Bookshelf_NBK326791.pdf
Recent Comments